Proyectos de Investigación
Project 101142365
RNA-based cancer ImmunotheraPeutics to Enhance CROssPrimming
Funder: COMISIÓN EUROPEA
Call: HORIZON-ERC-2023-ADG (COMISIÓN EUROPEA)
edit_calendar
Duration: from 01 October 2024 to 30 September 2029
(60 months)
Current
€2,411,500.00
Of European scope.